Loading...
•
Mar 31, 2023
Atricure Q1 2023 Earnings Report
Reported a strong start to the year with revenue growth and improved profitability.
Key Takeaways
AtriCure reported a strong first quarter in 2023, with a 25.4% increase in worldwide revenue year-over-year, driven by growth in both U.S. and international markets. The company also saw a significant improvement in net loss and achieved positive adjusted EBITDA.
Worldwide revenue increased by 25.4% year-over-year to $93.5 million.
U.S. revenue grew by 25.6% year-over-year to $78.2 million.
International revenue increased by 24.4% year-over-year to $15.3 million.
Net loss improved by $8.7 million year-over-year to $6.5 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
AtriCure projects full year 2023 revenue to be $385 million to $392 million, reflecting growth of approximately 17% to 19% over full year 2022. Management now expects full year 2023 positive adjusted EBITDA of approximately $2 million, and full year 2023 adjusted loss per share of approximately $1.10 to $1.15.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...